2 chapters across the catalog
The UK Department of Health is currently evaluating tenders for a massive HPV vaccination program, pitting Merck's Gardasil against Cervarix. An anonymous source warns of an upcoming PR blitz as the companies compete for the government contract. The discussion highlights that these vaccines use "virus-like particles" (VLPs) and questions the long-term safety and necessity of injecting children with synthetic viral proteins.
Cervarix HPV Vaccine Death and Inquest Results
The death of 14-year-old Natalie Morton in England shortly after receiving the Cervarix HPV vaccine is discussed. While the initial investigation led to a temporary halt in vaccinations, the hosts report that a pathologist later attributed the death to a "malignant tumor of unknown origin" in the heart and lungs. They express skepticism about the "coincidence" and the rapid reinstatement of the vaccination program.
